House Judiciary panel approves bills to boost drug competition
The House Judiciary Committee approved several bills that would place more restrictions on branded drugmakers that try to limit competition from generic drug companies. The full House could take up the...To view the full article, register now.
Already a subscriber? Click here to view full article